APHS continues to expand within the oncology industry, servicing an extensive customer base from the eastern to the western coast of Australia.

Oncology facilities and practitioners recognise us as a market leader and the continued strengthening of our position in a growing marketplace like oncology augers well for the future.

We have compounding capabilities at a number of our Oncology sites, but our Joint Venture agreement with Baxter Healthcare gives us access to TGA approved oncology products for the benefits of our customers.